Logout  |  Home
 
  Resources   JobSeekers   Employers   Recruiters  
 

Kendle International

Kendle (Nasdaq: KNDL) is the world's fourth largest provider of phase II-IV global clinical development services. We deliver innovative and robust clinical development solutions – from first-in-human studies through market launch and surveillance – to help the world's biopharmaceutical companies maximize product life cycles and grow market share. Kendle has a 25-year history of serving customers, both large and small, and with a diversity of compounds, which means that our expertise spans every major therapeutic area. We are focused on growing Phase I-IV clinical development expertise in the top five therapeutic areas expected to represent 70 percent of R&D spending by 2009: cardiology, oncology, antibiotics and antivirals, central nervous system and arthritis/inflammation. With headquarters in Cincinnati, Ohio and approximately 3,000 associates worldwide, Kendle has conducted clinical trials or provided regulatory and validation services in 70 countries. Our global clinical development business is focused on five regions --- North America, Europe, Asia/Pacific, Latin America, and Africa. Our mission - Kendle is a global clinical research organization that provides the biopharmaceutical industry with outstanding strategy as well as a full complement of quality clinical development and regulatory services to accelerate the drug development process. We live our 'Real people'. Real results.® statement every day as we work in partnership with companies to help speed their drugs to market, making a real difference to the quality of life of people around the world.